Neuroendocrine tumors, version 1.2015

Matthew H. Kulke, Manisha H. Shah, Al B. Benson, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Lyska Emerson, Paul F. Engstrom, Paul Fanta, Thomas Giordano, Whitney S. Goldner, Thorvardur R. Halfdanarson, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff, Christopher Lieu, Jeffrey F. Moley, Gitonga Munene, Venu G. PillarisettyLeonard Saltz, Julie Ann Sosa, Jonathan R. Strosberg, Jean Nicolas Vauthey, Christopher Wolfgang, James C. Yao, Jennifer Burns, Deborah Freedman-Cass

Research output: Contribution to journalArticlepeer-review

288 Scopus citations


Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Neuroendocrine Tumors discuss the diagnosis and management of both sporadic and hereditary NETs. This selection from the guidelines focuses on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus.

Original languageEnglish (US)
Pages (from-to)78-108
Number of pages31
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number1
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Neuroendocrine tumors, version 1.2015'. Together they form a unique fingerprint.

Cite this